Francisella tularensis is the causative organism of the disease tularemia. The extreme pathogenic and infectious properties of this organism, as well as its ease of dissemination, make it a plausible candidate for use in a biological weapon. F. tularensis can be rendered even more dangerous by its aerosolization and by transformation with plasmids encoding resistance to antibiotics. It is therefore imperative to explore novel therapies for inhaled F. tularensis that do not rely on the use of these drugs. Developing such therapies would be facilitated by an improved understanding of the host genes participating in the clearance of F. tularensis from the lungs of experimental mice. Toward that end, I propose to use two parallel gene identification strategies: quantitative trait locus (QTL) mapping, and microarray-based gene expression studies. Individually, each of these approaches yields more candidate genes than can be feasibly pursued within the time limits of this proposal. To overcome this problem, I will reduce the candidate gene number to a manageable level by selecting only those genes that are contained within identified QTL and that are induced by F. tularensis infection. This comparatively small subset is likely to contain genes causally associated with susceptibility to F. tularensis. These genes will be tested for their biologic relevance by selectively suppressing them in cultured macrophages using short interference RNA (siRNA). Macrophages transfected with gene-specific, siRNA-expressing plasmids will be compared to their untransfected counterparts for their abilities to support proliferation of F. tularensis in vitro. Biologically validated genes emerging from these studies will represent novel molecular targets whose actions might be manipulated by therapies designed to improve the innate immune response to F. tularensis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI058161-02
Application #
6954104
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Schaefer, Michael R
Project Start
2004-09-30
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2007-08-31
Support Year
2
Fiscal Year
2005
Total Cost
$262,100
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Brass, David M; Hollingsworth, John W; Cinque, Mark et al. (2008) Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol 39:584-90
Garantziotis, Stavros; Hollingsworth, John W; Zaas, Aimee K et al. (2008) The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59:343-59
Marraccini, P; Brass, D M; Hollingsworth, J W et al. (2008) Bakery flour dust exposure causes non-allergic inflammation and enhances allergic airway inflammation in mice. Clin Exp Allergy 38:1526-35
Hollingsworth, John W; Kleeberger, Steven R; Foster, W Michael (2007) Ozone and pulmonary innate immunity. Proc Am Thorac Soc 4:240-6
Hollingsworth, John W; Whitehead, Gregory; Berman, Katherine Gray et al. (2007) Genetic basis of murine antibacterial defense to streptococcal lung infection. Immunogenetics 59:713-24
Hollingsworth, John W; Maruoka, Shuichiro; Li, Zhuowei et al. (2007) Ambient ozone primes pulmonary innate immunity in mice. J Immunol 179:4367-75
Hollingsworth, J W; Shofer, S; Zaas, A (2007) Successful treatment of Ochroconis gallopavum infection in an immunocompetent host. Infection 35:367-9
Hollingsworth, John W; Li, Zhuowei; Brass, David M et al. (2007) CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. Am J Respir Cell Mol Biol 37:248-53